<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Infectious Diseases and Immunology Publications and Presentations</title>
<copyright>Copyright (c) 2013 University of Massachusetts Medical School All rights reserved.</copyright>
<link>http://escholarship.umassmed.edu/infdis_pp</link>
<description>Recent documents in Infectious Diseases and Immunology Publications and Presentations</description>
<language>en-us</language>
<lastBuildDate>Fri, 17 May 2013 01:47:15 PDT</lastBuildDate>
<ttl>3600</ttl>


	
		
	







<item>
<title>Ecdysone triggered PGRP-LC expression controls Drosophila innate immunity</title>
<link>http://escholarship.umassmed.edu/infdis_pp/157</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/157</guid>
<pubDate>Wed, 15 May 2013 09:10:52 PDT</pubDate>
<description>
	<![CDATA[
	<p>Throughout the animal kingdom, steroid hormones have been implicated in the defense against microbial infection, but how these systemic signals control immunity is unclear. Here, we show that the steroid hormone ecdysone controls the expression of the pattern recognition receptor PGRP-LC in Drosophila, thereby tightly regulating innate immune recognition and defense against bacterial infection. We identify a group of steroid-regulated transcription factors as well as two GATA transcription factors that act as repressors and activators of the immune response and are required for the proper hormonal control of PGRP-LC expression. Together, our results demonstrate that Drosophila use complex mechanisms to modulate innate immune responses, and identify a transcriptional hierarchy that integrates steroid signalling and immunity in animals.</p>

	]]>
</description>

<author>Florentina Rus et al.</author>


<category>Ecdysone</category>

<category>Steroids</category>

<category>Carrier Proteins</category>

<category>Drosophila</category>

<category>Drosophila Proteins</category>

<category>Immunity, Innate</category>

</item>






<item>
<title>Dermatophagoides pteronyssinus Major Allergen 1 Activates the Innate Immune Response of the Fruit Fly Drosophila melanogaster</title>
<link>http://escholarship.umassmed.edu/infdis_pp/156</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/156</guid>
<pubDate>Tue, 05 Feb 2013 05:59:19 PST</pubDate>
<description>
	<![CDATA[
	<p>Some allergens with relevant protease activity have the potential to directly interact with host structures. It remains to be elucidated whether this activity is relevant for developing their allergenic properties. The major goal of this study was to elucidate whether allergens with a strong protease activity directly interact with modules of the innate immune system, thereby inducing an immune response. We chose Drosophila melanogaster for our experiments to prevent the results from being influenced by the adaptive immune system and used the armamentarium of methods available for the fly to study the underlying mechanisms. We show that Dermatophagoides pteronyssinus major allergen 1 (Der p 1), the major allergen of the house dust mite, efficiently activates various facets of the Drosophila innate-immune system, including both epithelial and systemic responses. These responses depend on the immune deficiency (IMD) pathway via activation of the NF-κB transcription factor Relish. In addition, the major pathogen associated molecular pattern recognizing receptor of the IMD pathway, peptidoglycan recognition protein-LC, was necessary for this response. We showed that Der p 1, which has cysteine protease activity, cleaves the ectodomain of peptidoglycan recognition protein-LC and, thus, activates the IMD pathway to induce a profound immune response. We conclude that the innate immune response to this allergen-mediated proteolytic cleavage represents an ancient type of danger signaling that may be highly relevant for the primary allergenicity of compounds such as Der p 1.</p>

	]]>
</description>

<author>Christine Warmbold et al.</author>


<category>Antigens, Dermatophagoides</category>

<category>Arthropod Proteins</category>

<category>Drosophila melanogaster</category>

<category>Immunity, Innate</category>

<category>Drosophila Proteins</category>

</item>






<item>
<title>Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway</title>
<link>http://escholarship.umassmed.edu/infdis_pp/155</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/155</guid>
<pubDate>Mon, 04 Feb 2013 12:22:24 PST</pubDate>
<description>
	<![CDATA[
	<p>Although infections with virulent pathogens often induce a strong inflammatory reaction, what drives the increased immune response to pathogens compared to nonpathogenic microbes is poorly understood. One possibility is that the immune system senses the level of threat from a microorganism and augments the response accordingly. Here, focusing on cytotoxic necrotizing factor 1 (CNF1), an Escherichia coli-derived effector molecule, we showed the host indirectly sensed the pathogen by monitoring for the effector that modified RhoGTPases. CNF1 modified Rac2, which then interacted with the innate immune adaptors IMD and Rip1-Rip2 in flies and mammalian cells, respectively, to drive an immune response. This response was protective and increased the ability of the host to restrict pathogen growth, thus defining a mechanism of effector-triggered immunity that contributes to how metazoans defend against microbes with pathogenic potential.</p>

	]]>
</description>

<author>Laurent Boyer et al.</author>


<category>Adaptor Proteins, Signal Transducing</category>

<category>Enzyme Activation</category>

<category>HEK293 Cells</category>

<category>Humans</category>

<category>Receptor-Interacting Protein Serine-Threonine Kinases</category>

<category>*Signal Transduction</category>

<category>rac GTP-Binding Proteins</category>

</item>






<item>
<title>UnZIPping mechanisms of effector-triggered immunity in animals</title>
<link>http://escholarship.umassmed.edu/infdis_pp/153</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/153</guid>
<pubDate>Mon, 04 Feb 2013 12:22:23 PST</pubDate>
<description>
	<![CDATA[
	<p>The mechanisms by which epithelial cells distinguish pathogens from commensal microbes have long puzzled us. Now, McEwan et al. (2012) and Dunbar et al. (2012), in this issue of Cell Host and Microbe, demonstrate that in C. elegans, microbial toxin-induced inhibition of host cellular functions, especially blockade of protein translation, activates the effector-triggered immune response dependent on the transcription factor ZIP-2.</p>

	]]>
</description>

<author>Anni Kleino et al.</author>


<category>Bacterial Toxins</category>

<category>Caenorhabditis elegans</category>

<category>Exotoxins</category>

<category>Protein Biosynthesis</category>

<category>Pseudomonas Infections</category>

<category>Pseudomonas aeruginosa</category>

</item>






<item>
<title>Bacterial effectors: learning on the fly</title>
<link>http://escholarship.umassmed.edu/infdis_pp/154</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/154</guid>
<pubDate>Mon, 04 Feb 2013 12:22:23 PST</pubDate>
<description>
	<![CDATA[
	<p>A common defining characteristic of pathogenic bacteria is the expression of a repertoire of effector molecules that have been named virulence factors. These bacterial factors include a -variety of proteins, such as toxins that are internalized by receptors and translocate across endosomal membranes to reach the cytosol, as well as others that are introduced directly into the cell by means of bacterial secretory apparatuses. Given the importance of these effectors for understanding bacterial pathogenicity, significant effort has been made to dissect their molecular mechanisms of action and their respective roles during infection. Herein we will discuss how Drosophila have been used as a model system to study these important microbial effectors, and to understand their contribution to pathogenicity.</p>

	]]>
</description>

<author>Laurent Boyer et al.</author>


<category>Animals</category>

<category>Antigens, Bacterial</category>

<category>Bacteria</category>

<category>Bacterial Proteins</category>

<category>Drosophila melanogaster</category>

<category>GTPase-Activating Proteins</category>

<category>Immunity, Innate</category>

<category>Inflammation</category>

<category>Virulence Factors</category>

<category>rho GTP-Binding Proteins</category>

</item>






<item>
<title>Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling</title>
<link>http://escholarship.umassmed.edu/infdis_pp/152</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/152</guid>
<pubDate>Mon, 04 Feb 2013 12:22:22 PST</pubDate>
<description>
	<![CDATA[
	<p>Caspases have been extensively studied as critical initiators and executioners of cell death pathways. However, caspases also take part in non-apoptotic signalling events such as the regulation of innate immunity and activation of nuclear factor-kappaB (NF-kappaB). How caspases are activated under these conditions and process a selective set of substrates to allow NF-kappaB signalling without killing the cell remains largely unknown. Here, we show that stimulation of the Drosophila pattern recognition protein PGRP-LCx induces DIAP2-dependent polyubiquitylation of the initiator caspase DREDD. Signal-dependent ubiquitylation of DREDD is required for full processing of IMD, NF-kappaB/Relish and expression of antimicrobial peptide genes in response to infection with Gram-negative bacteria. Our results identify a mechanism that positively controls NF-kappaB signalling via ubiquitin-mediated activation of DREDD. The direct involvement of ubiquitylation in caspase activation represents a novel mechanism for non-apoptotic caspase-mediated signalling.</p>

	]]>
</description>

<author>Annika Meinander et al.</author>


<category>Animals</category>

<category>Antimicrobial Cationic Peptides</category>

<category>Carrier Proteins</category>

<category>Caspases</category>

<category>Drosophila</category>

<category>Drosophila Proteins</category>

<category>*Gene Expression Regulation</category>

<category>Gram-Negative Bacteria</category>

<category>Immunity, Innate</category>

<category>Inhibitor of Apoptosis Proteins</category>

<category>Models, Biological</category>

<category>NF-kappa B</category>

<category>Transcription Factors</category>

<category>*Ubiquitination</category>

</item>






<item>
<title>Characterization of poxvirus-encoded proteins that regulate innate immune signaling pathways</title>
<link>http://escholarship.umassmed.edu/infdis_pp/151</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/151</guid>
<pubDate>Mon, 04 Feb 2013 12:22:21 PST</pubDate>
<description>
	<![CDATA[
	<p>Innate immune recognition of pathogens is critical to the prompt control of infections, permitting the host to survive to develop long-term immunity via an adaptive immune response. Poxviruses encode a family of proteins that inhibit signaling by Toll-like receptors to their downstream signaling components, severely limiting nuclear translocation of transcription factors such as IRF3 and NF-kappaB and thereby decreasing production of host interferons and cytokines. We describe bioinformatics techniques for identifying candidate poxviral inhibitors of the innate immune response based on similarity to the family of proteins that includes A52, A46, and N1. Robust luciferase assays can determine whether a given poxviral gene affects innate immune signaling, and in combination with other approaches can identify the cellular targets of poxviral innate immune evasion genes. Because apoptosis is an innate immune response of the cell to viral infection, assays for identifying poxviral genes that inhibit apoptosis can also be employed. Novel poxviral innate immune inhibitors are being identified via several approaches and these techniques promise to identify further complexities in the way that poxviruses interact with the host innate immune system.</p>

	]]>
</description>

<author>Florentina Rus et al.</author>


<category>Amino Acid Sequence</category>

<category>Apoptosis</category>

<category>Cloning, Molecular</category>

<category>Flow Cytometry</category>

<category>Genes, Reporter</category>

<category>HEK293 Cells</category>

<category>HeLa Cells</category>

<category>*Host-Pathogen Interactions</category>

<category>Humans</category>

<category>Immune Evasion</category>

<category>*Immunity, Innate</category>

<category>Immunomodulation</category>

<category>Immunoprecipitation</category>

<category>Luciferases, Firefly</category>

<category>Luciferases, Renilla</category>

<category>Molecular Sequence Data</category>

<category>Phylogeny</category>

<category>Protein Binding</category>

<category>*Signal Transduction</category>

<category>Toll-Like Receptors</category>

<category>Vaccinia virus</category>

<category>Viral Proteins</category>

</item>






<item>
<title>Regulation of inflammasome signaling</title>
<link>http://escholarship.umassmed.edu/infdis_pp/150</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/150</guid>
<pubDate>Mon, 04 Feb 2013 12:22:20 PST</pubDate>
<description>
	<![CDATA[
	<p>Innate immune responses have the ability to both combat infectious microbes and drive pathological inflammation. Inflammasome complexes are a central component of these processes through their regulation of interleukin 1beta (IL-1beta), IL-18 and pyroptosis. Inflammasomes recognize microbial products or endogenous molecules released from damaged or dying cells both through direct binding of ligands and indirect mechanisms. The potential of the IL-1 family of cytokines to cause tissue damage and chronic inflammation emphasizes the importance of regulating inflammasomes. Many regulatory mechanisms have been identified that act as checkpoints for attenuating inflammasome signaling at multiple steps. Here we discuss the various regulatory mechanisms that have evolved to keep inflammasome signaling in check to maintain immunological balance.</p>

	]]>
</description>

<author>Vijay A. K. Rathinam et al.</author>


<category>Animals</category>

<category>Humans</category>

<category>Immunity, Innate</category>

<category>Inflammasomes</category>

<category>Signal Transduction</category>

</item>






<item>
<title>Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor</title>
<link>http://escholarship.umassmed.edu/infdis_pp/149</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/149</guid>
<pubDate>Mon, 04 Feb 2013 12:22:19 PST</pubDate>
<description>
	<![CDATA[
	<p>Recognition of DNA by the innate immune system is central to antiviral and antibacterial defenses, as well as an important contributor to autoimmune diseases involving self DNA. AIM2 (absent in melanoma 2) and IFI16 (interferon-inducible protein 16) have been identified as DNA receptors that induce inflammasome formation and interferon production, respectively. Here we present the crystal structures of their HIN domains in complex with double-stranded (ds) DNA. Non-sequence-specific DNA recognition is accomplished through electrostatic attraction between the positively charged HIN domain residues and the dsDNA sugar-phosphate backbone. An intramolecular complex of the AIM2 Pyrin and HIN domains in an autoinhibited state is liberated by DNA binding, which may facilitate the assembly of inflammasomes along the DNA staircase. These findings provide mechanistic insights into dsDNA as the activation trigger and oligomerization platform for the assembly of large innate signaling complexes such as the inflammasomes.</p>

	]]>
</description>

<author>Tengchuan Jin et al.</author>


<category>Amino Acid Sequence</category>

<category>Cell Line</category>

<category>Crystallography, X-Ray</category>

<category>DNA, B-Form</category>

<category>DNA-Binding Proteins</category>

<category>Humans</category>

<category>Immunity, Innate</category>

<category>Inflammasomes</category>

<category>Models, Molecular</category>

<category>Molecular Sequence Data</category>

<category>Nuclear Proteins</category>

<category>Phosphoproteins</category>

<category>Protein Binding</category>

<category>Protein Folding</category>

<category>Protein Structure, Tertiary</category>

<category>Signal Transduction</category>

</item>






<item>
<title>TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia</title>
<link>http://escholarship.umassmed.edu/infdis_pp/147</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/147</guid>
<pubDate>Mon, 04 Feb 2013 12:22:18 PST</pubDate>
<description>
	<![CDATA[
	<p>Preterm birth, the major cause of neonatal mortality in developed countries, is associated with intrauterine infections and inflammation, although the exact mechanisms underlying this event are unclear. In this study, we show that circulating fetal DNA, which is elevated in pregnancies complicated by preterm labor or preeclampsia, triggers an inflammatory reaction that results in spontaneous preterm birth. Fetal DNA activates NF-kappaB, shown by IkappaBalpha degradation in human PBMCs resulting in production of proinflammatory IL-6. We show that fetal resorption and preterm birth are rapidly induced in mice after i.p. injection of CpG or fetal DNA (300 mug/dam) on gestational day 10-14. In contrast, TLR9(-/-) mice were protected from these effects. Furthermore, this effect was blocked by oral administration of the TLR9 inhibitor chloroquine. Our data therefore provide a novel mechanism for preterm birth and preeclampsia, highlighting TLR9 as a potential therapeutic target for these common disorders of pregnancy.</p>

	]]>
</description>

<author>Andrea Scharfe-Nugent et al.</author>


<category>Adult</category>

<category>Animals</category>

<category>Cell Line, Tumor</category>

<category>Cells, Cultured</category>

<category>DNA</category>

<category>Female</category>

<category>Fetal Death</category>

<category>Humans</category>

<category>Inflammation Mediators</category>

<category>Male</category>

<category>Mice</category>

<category>Mice, Inbred BALB C</category>

<category>Mice, Inbred C57BL</category>

<category>Mice, Knockout</category>

<category>Middle Aged</category>

<category>Pre-Eclampsia</category>

<category>Pregnancy</category>

<category>Premature Birth</category>

<category>Toll-Like Receptor 9</category>

</item>






<item>
<title>Immunology. Select inflammasome assembly</title>
<link>http://escholarship.umassmed.edu/infdis_pp/148</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/148</guid>
<pubDate>Mon, 04 Feb 2013 12:22:18 PST</pubDate>
<description>
	<![CDATA[
	<p>Comment on: <a href="http://www.ncbi.nlm.nih.gov/pubmed/22461501">GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals.</a> [Science. 2012]</p>

	]]>
</description>

<author>Daniel R. Caffrey et al.</author>


<category>Animals</category>

<category>Carrier Proteins</category>

<category>GTP-Binding Proteins</category>

<category>Humans</category>

<category>Inflammasomes</category>

<category>Macrophages</category>

</item>






<item>
<title>DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation</title>
<link>http://escholarship.umassmed.edu/infdis_pp/146</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/146</guid>
<pubDate>Mon, 04 Feb 2013 12:22:16 PST</pubDate>
<description>
	<![CDATA[
	<p>The adaptors DOCK8 and MyD88 have been linked to serological memory. Here we report that DOCK8-deficient patients had impaired antibody responses and considerably fewer CD27(+) memory B cells. B cell proliferation and immunoglobulin production driven by Toll-like receptor 9 (TLR9) were considerably lower in DOCK8-deficient B cells, but those driven by the costimulatory molecule CD40 were not. In contrast, TLR9-driven expression of AICDA (which encodes the cytidine deaminase AID), the immunoglobulin receptor CD23 and the costimulatory molecule CD86 and activation of the transcription factor NF-kappaB, the kinase p38 and the GTPase Rac1 were intact. DOCK8 associated constitutively with MyD88 and the tyrosine kinase Pyk2 in normal B cells. After ligation of TLR9, DOCK8 became tyrosine-phosphorylated by Pyk2, bound the Src-family kinase Lyn and linked TLR9 to a Src-kinase Syk-transcription factor STAT3 cascade essential for TLR9-driven B cell proliferation and differentiation. Thus, DOCK8 functions as an adaptor in a TLR9-MyD88 signaling pathway in B cells.</p>

	]]>
</description>

<author>Haifa H. Jabara et al.</author>


<category>Adolescent</category>

<category>Animals</category>

<category>B-Lymphocytes</category>

<category>Cell Differentiation</category>

<category>Child</category>

<category>Child, Preschool</category>

<category>Flow Cytometry</category>

<category>Focal Adhesion Kinase 2</category>

<category>Guanine Nucleotide Exchange Factors</category>

<category>Humans</category>

<category>Immunologic Memory</category>

<category>Lymphocyte Activation</category>

<category>Mice</category>

<category>Mice, Inbred BALB C</category>

<category>Mice, Inbred C57BL</category>

<category>Mice, Knockout</category>

<category>Myeloid Differentiation Factor 88</category>

<category>Neutrophils</category>

<category>Phosphorylation</category>

<category>STAT3 Transcription Factor</category>

<category>Toll-Like Receptor 9</category>

<category>src-Family Kinases</category>

</item>






<item>
<title>Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING</title>
<link>http://escholarship.umassmed.edu/infdis_pp/145</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/145</guid>
<pubDate>Mon, 04 Feb 2013 12:22:15 PST</pubDate>
<description>
	<![CDATA[
	<p>The innate immune system senses infection by detecting either evolutionarily conserved molecules essential for the survival of microbes or the abnormal location of molecules. Here we demonstrate the existence of a previously unknown innate detection mechanism induced by fusion between viral envelopes and target cells. Virus-cell fusion specifically stimulated a type I interferon response with expression of interferon-stimulated genes, in vivo recruitment of leukocytes and potentiation of signaling via Toll-like receptor 7 (TLR7) and TLR9. The fusion-dependent response was dependent on the stimulator of interferon genes STING but was independent of DNA, RNA and viral capsid. We suggest that membrane fusion is sensed as a danger signal with potential implications for defense against enveloped viruses and various conditions of giant-cell formation.</p>

	]]>
</description>

<author>Christian K. Holm et al.</author>


<category>Animals</category>

<category>*Cell Fusion</category>

<category>Chemokine CXCL10</category>

<category>HEK293 Cells</category>

<category>HeLa Cells</category>

<category>Herpesvirus 1, Human</category>

<category>Humans</category>

<category>*Immunity, Innate</category>

<category>Interferon Type I</category>

<category>Leukocytes</category>

<category>Lymphocyte Activation</category>

<category>Macrophages</category>

<category>*Membrane Fusion</category>

<category>Membrane Glycoproteins</category>

<category>Membrane Proteins</category>

<category>Mice</category>

<category>Mice, Knockout</category>

<category>Myeloid Differentiation Factor 88</category>

<category>Signal Transduction</category>

<category>Toll-Like Receptor 7</category>

<category>Toll-Like Receptor 9</category>

<category>Virus Internalization</category>

</item>






<item>
<title>Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling</title>
<link>http://escholarship.umassmed.edu/infdis_pp/144</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/144</guid>
<pubDate>Mon, 04 Feb 2013 12:22:14 PST</pubDate>
<description>
	<![CDATA[
	<p>The Gram-negative bacteria Yersinia pestis, causative agent of plague, is extremely virulent. One mechanism contributing to Y. pestis virulence is the presence of a type-three secretion system, which injects effector proteins, Yops, directly into immune cells of the infected host. One of these Yop proteins, YopJ, is proapoptotic and inhibits mammalian NF-kappaB and MAP-kinase signal transduction pathways. Although the molecular mechanism remained elusive for some time, recent work has shown that YopJ acts as a serine/threonine acetyl-transferase targeting MAP2 kinases. Using Drosophila as a model system, we find that YopJ inhibits one innate immune NF-kappaB signaling pathway (IMD) but not the other (Toll). In fact, we show YopJ mediated serine/threonine acetylation and inhibition of dTAK1, the critical MAP3 kinase in the IMD pathway. Acetylation of critical serine/threonine residues in the activation loop of Drosophila TAK1 blocks phosphorylation of the protein and subsequent kinase activation. In addition, studies in mammalian cells show similar modification and inhibition of hTAK1. These data present evidence that TAK1 is a target for YopJ-mediated inhibition.</p>

	]]>
</description>

<author>Nicholas Paul Paquette et al.</author>


<category>Acetylation</category>

<category>Animals</category>

<category>Bacterial Proteins</category>

<category>Drosophila melanogaster</category>

<category>HEK293 Cells</category>

<category>Humans</category>

<category>*Immunity, Innate</category>

<category>MAP Kinase Kinase Kinases</category>

<category>*MAP Kinase Signaling System</category>

<category>NF-kappa B</category>

<category>Plague</category>

<category>Serine O-Acetyltransferase</category>

<category>Yersinia pestis</category>

</item>






<item>
<title>Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection</title>
<link>http://escholarship.umassmed.edu/infdis_pp/142</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/142</guid>
<pubDate>Mon, 04 Feb 2013 12:22:13 PST</pubDate>
<description>
	<![CDATA[
	<p>Type I interferons (IFNs), predominantly IFN-alpha and -beta, play critical roles in both innate and adaptive immune responses against viral infections. Interferon regulatory factor 7 (IRF7), a key innate immune molecule in the type I IFN signaling pathway, is essential for the type I IFN response to many viruses, including lymphocytic choriomeningitis virus (LCMV). Here, we show that although IRF7 knockout (KO) mice failed to control the replication of LCMV in the early stages of infection, they were capable of clearing LCMV infection. Despite the lack of type I IFN production, IRF7 KO mice generated normal CD4(+) T cell responses, and the expansion of naive CD8(+) T cells into primary CD8(+) T cells specific for LCMV GP(33-41) was relatively normal. In contrast, the expansion of the LCMV NP(396)-specific CD8(+) T cells was severely impaired in IRF7 KO mice. We demonstrated that this defective CD8(+) T cell response is due neither to an impaired antigen-presenting system nor to any intrinsic role of IRF7 in CD8(+) T cells. The lack of a type I IFN response in IRF7 KO mice did not affect the formation of memory CD8(+) T cells. Thus, the present study provides new insight into the impact of the innate immune system on viral pathogenesis and demonstrates the critical contribution of innate immunity in controlling virus replication in the early stages of infection, which may shape the quality of CD8(+) T cell responses.</p>

	]]>
</description>

<author>Shenghua Zhou et al.</author>


<category>Adaptive Immunity</category>

<category>Animals</category>

<category>CD4-Positive T-Lymphocytes</category>

<category>CD8-Positive T-Lymphocytes</category>

<category>Immunity, Innate</category>

<category>Interferon Regulatory Factor-7</category>

<category>Interferon Type I</category>

<category>Lymphocyte Activation</category>

<category>Lymphocytic Choriomeningitis</category>

<category>Lymphocytic choriomeningitis virus</category>

<category>Mice</category>

<category>Mice, Inbred C57BL</category>

<category>Mice, Knockout</category>

<category>Signal Transduction</category>

<category>Virus Replication</category>

</item>






<item>
<title>TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria</title>
<link>http://escholarship.umassmed.edu/infdis_pp/143</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/143</guid>
<pubDate>Mon, 04 Feb 2013 12:22:13 PST</pubDate>
<description>
	<![CDATA[
	<p>Systemic infections with Gram-negative bacteria are characterized by high mortality rates due to the "sepsis syndrome," a widespread and uncontrolled inflammatory response. Though it is well recognized that the immune response during Gram-negative bacterial infection is initiated after the recognition of endotoxin by Toll-like receptor 4, the molecular mechanisms underlying the detrimental inflammatory response during Gram-negative bacteremia remain poorly defined. Here, we identify a TRIF pathway that licenses NLRP3 inflammasome activation by all Gram-negative bacteria. By engaging TRIF, Gram-negative bacteria activate caspase-11. TRIF activates caspase-11 via type I IFN signaling, an event that is both necessary and sufficient for caspase-11 induction and autoactivation. Caspase-11 subsequently synergizes with the assembled NLRP3 inflammasome to regulate caspase-1 activation and leads to caspase-1-independent cell death. These events occur specifically during infection with Gram-negative, but not Gram-positive, bacteria. The identification of TRIF as a regulator of caspase-11 underscores the importance of TLRs as master regulators of inflammasomes during Gram-negative bacterial infection.</p>

	]]>
</description>

<author>Vijay A. K. Rathinam et al.</author>


<category>Adaptor Proteins, Vesicular Transport</category>

<category>Animals</category>

<category>Carrier Proteins</category>

<category>Caspases</category>

<category>Citrobacter rodentium</category>

<category>Enterohemorrhagic Escherichia coli</category>

<category>Gram-Negative Bacteria</category>

<category>Gram-Positive Bacteria</category>

<category>Inflammasomes</category>

<category>Interferons</category>

<category>Mice</category>

<category>Signal Transduction</category>

</item>






<item>
<title>NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity</title>
<link>http://escholarship.umassmed.edu/infdis_pp/141</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/141</guid>
<pubDate>Mon, 04 Feb 2013 12:22:12 PST</pubDate>
<description>
	<![CDATA[
	<p>Prion diseases are fatal transmissible neurodegenerative diseases, characterized by aggregation of the pathological form of prion protein, spongiform degeneration, and neuronal loss, and activation of astrocytes and microglia. Microglia can clear prion plaques, but on the other hand cause neuronal death via release of neurotoxic species. Elevated expression of the proinflammatory cytokine IL-1beta has been observed in brains affected by several prion diseases, and IL-1R-deficiency significantly prolonged the onset of the neurodegeneration in mice. We show that microglial cells stimulated by prion protein (PrP) fibrils induced neuronal toxicity. Microglia and macrophages release IL-1beta upon stimulation by PrP fibrils, which depends on the NLRP3 inflammasome. Activation of NLRP3 inflammasome by PrP fibrils requires depletion of intracellular K(+), and requires phagocytosis of PrP fibrils and consecutive lysosome destabilization. Among the well-defined molecular forms of PrP, the strongest NLRP3 activation was observed by fibrils, followed by aggregates, while neither native monomeric nor oligomeric PrP were able to activate the NLRP3 inflammasome. Our results together with previous studies on IL-1R-deficient mice suggest the IL-1 signaling pathway as the perspective target for the therapy of prion disease.</p>

	]]>
</description>

<author>Iva Hafner-Bratkovic et al.</author>


<category>Prion Diseases</category>

<category>Carrier Proteins</category>

<category>Inflammasomes</category>

<category>Interleukin-1beta</category>

</item>






<item>
<title>5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential</title>
<link>http://escholarship.umassmed.edu/infdis_pp/140</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/140</guid>
<pubDate>Mon, 04 Feb 2013 12:22:11 PST</pubDate>
<description>
	<![CDATA[
	<p>The chemotherapeutic agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a potent inducer of type I IFNs and other cytokines. This ability is essential for its chemotherapeutic benefit in a mouse cancer model and suggests that it might also be useful as an antiviral agent. However, the mechanism underlying DMXAA-induced type I IFNs, including the host proteins involved, remains unclear. Recently, it was reported that the antioxidant N-acetylcysteine (NAC) decreased DMXAA-induced TNF-alpha and IL-6, suggesting that oxidative stress may play a role. The goal of this study was to identify host proteins involved in DMXAA-dependent signaling and determine how antioxidants modulate this response. We found that expression of IFN-beta in response to DMXAA in mouse macrophages requires the mitochondrial and endoplasmic reticulum resident protein STING. Addition of the antioxidant diphenylene iodonium (DPI) diminished DMXAA-induced IFN-beta, but this decrease was independent of both the NADPH oxidase, Nox2, and de novo generation of reactive oxygen species. Additionally, IFN-beta up-regulation by DMXAA was inhibited by agents that target the mitochondrial electron transport chain and, conversely, loss of mitochondrial membrane potential correlated with diminished innate immune signaling in response to DMXAA. Up-regulation of Ifnb1 gene expression mediated by cyclic dinucleotides was also impaired by DPI, whereas up-regulation of Ifnb1 mRNA due to cytosolic double-stranded DNA was not. Although both stimuli signal through STING, cyclic dinucleotides interact directly with STING, suggesting that recognition of DMXAA by STING may also be mediated by direct interaction.</p>

	]]>
</description>

<author>Daniel Prantner et al.</author>


<category>Xanthones</category>

<category>Membrane Proteins</category>

<category>Antioxidants</category>

<category>Signal Transduction</category>

</item>






<item>
<title>Cutting Edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner</title>
<link>http://escholarship.umassmed.edu/infdis_pp/139</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/139</guid>
<pubDate>Mon, 04 Feb 2013 12:22:10 PST</pubDate>
<description>
	<![CDATA[
	<p>Fas, a TNF family receptor, is activated by the membrane protein Fas ligand expressed on various immune cells. Fas signaling triggers apoptosis and induces inflammatory cytokine production. Among the Fas-induced cytokines, the IL-1beta family cytokines require proteolysis to gain biological activity. Inflammasomes, which respond to pathogens and danger signals, cleave IL-1beta cytokines via caspase-1. However, the mechanisms by which Fas regulates IL-1beta activation remain unresolved. In this article, we demonstrate that macrophages exposed to TLR ligands upregulate Fas, which renders them responsive to receptor engagement by Fas ligand. Fas signaling activates caspase-8 in macrophages and dendritic cells, leading to the maturation of IL-1beta and IL-18 independently of inflammasomes or RIP3. Hence, Fas controls a novel noncanonical IL-1beta activation pathway in myeloid cells, which could play an essential role in inflammatory processes, tumor surveillance, and control of infectious diseases.</p>

	]]>
</description>

<author>Lukas Bossaller et al.</author>


<category>Fas Ligand Protein</category>

<category>Interleukin-1beta</category>

<category>Interleukin-18</category>

</item>






<item>
<title>Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome</title>
<link>http://escholarship.umassmed.edu/infdis_pp/138</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/infdis_pp/138</guid>
<pubDate>Mon, 30 Jul 2012 13:01:00 PDT</pubDate>
<description>
	<![CDATA[
	<p>Although Toll-like receptor 9 (TLR9) has been implicated in cytokine and type I interferon (IFN) production during malaria in humans and mice, the high AT content of the Plasmodium falciparum genome prompted us to examine the possibility that malarial DNA triggered TLR9-independent pathways. Over 6000 ATTTTTAC ("AT-rich") motifs are present in the genome of P. falciparum, which we show here potently induce type I IFNs. Parasite DNA, parasitized erythrocytes and oligonucleotides containing the AT-rich motif induce type I IFNs via a pathway that did not involve the previously described sensors TLR9, DAI, RNA polymerase-III or IFI16/p204. Rather, AT-rich DNA sensing involved an unknown receptor that coupled to the STING, TBK1 and IRF3-IRF7 signaling pathway. Mice lacking IRF3, IRF7, the kinase TBK1 or the type I IFN receptor were resistant to otherwise lethal cerebral malaria. Collectively, these observations implicate AT-rich DNA sensing via STING, TBK1 and IRF3-IRF7 in P. falciparum malaria.</p>

	]]>
</description>

<author>Shrutie Sharma et al.</author>


<category>AT Rich Sequence</category>

<category>Animals</category>

<category>DNA, Protozoan</category>

<category>Gene Expression Profiling</category>

<category>Humans</category>

<category>Immunity, Innate</category>

<category>Interferon Regulatory Factor-3</category>

<category>Interferon Regulatory Factor-7</category>

<category>Interferon Type I</category>

<category>Malaria, Falciparum</category>

<category>Membrane Proteins</category>

<category>Mice</category>

<category>Mice, Knockout</category>

<category>Oligonucleotides</category>

<category>Plasmodium falciparum</category>

<category>Protein-Serine-Threonine Kinases</category>

<category>Receptor, Interferon alpha-beta</category>

<category>Signal Transduction</category>

</item>





</channel>
</rss>
